![Pascal Brenneisen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Pascal Brenneisen
Chief Executive Officer at TOPADUR Pharma AG
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Reto Naef | M | - |
TOPADUR Pharma AG
![]() TOPADUR Pharma AG Pharmaceuticals: MajorHealth Technology TOPADUR Pharma AG is a Swiss-based biotech company located in Schlieren. TOPADUR is a patient-oriented biotech company that aims to enhance the quality of life through cutting-edge research. The private company is developing a new class of compounds based on their innovative cgmp-enzyme regulation system, which corrects locally cgmp levels. These compounds target high medical needs and can be used to treat several ageing-related diseases resulting from insufficient local blood-circulation. The company was founded in 2015 by Reto Naef, who has been the CEO since then. | 9 years |
Bekim Osmani | M | - |
Bottneuro AG
![]() Bottneuro AG Information Technology ServicesTechnology Services Bottneuro AG develops digital therapies for Alzheimer's disease by using electrical stimulation of glia cells in the brain. The company is based in Basel, Switzerland. The Swiss company was founded by Bekim Osmani, Alois C. Hopf, and Bekim Osmani has been the CEO since incorporation. | - |
James Kone | M | - |
Stratpharma AG
![]() Stratpharma AG Pharmaceuticals: MajorHealth Technology Stratpharma AG specializes in the development and licensing of novel medical devices and pharmaceutical products. Its products are used for scar management, abnormal scar prevention and invasive therapies. The company was founded in 2005 and is headquartered in Basel, Switzerland.^ | 7 years |
Eric Gisiger | M | - |
Stratpharma AG
![]() Stratpharma AG Pharmaceuticals: MajorHealth Technology Stratpharma AG specializes in the development and licensing of novel medical devices and pharmaceutical products. Its products are used for scar management, abnormal scar prevention and invasive therapies. The company was founded in 2005 and is headquartered in Basel, Switzerland.^ | - |
Luka Valas | M | - |
Stratpharma AG
![]() Stratpharma AG Pharmaceuticals: MajorHealth Technology Stratpharma AG specializes in the development and licensing of novel medical devices and pharmaceutical products. Its products are used for scar management, abnormal scar prevention and invasive therapies. The company was founded in 2005 and is headquartered in Basel, Switzerland.^ | 16 years |
Christian Ludin | M | - |
TOPADUR Pharma AG
![]() TOPADUR Pharma AG Pharmaceuticals: MajorHealth Technology TOPADUR Pharma AG is a Swiss-based biotech company located in Schlieren. TOPADUR is a patient-oriented biotech company that aims to enhance the quality of life through cutting-edge research. The private company is developing a new class of compounds based on their innovative cgmp-enzyme regulation system, which corrects locally cgmp levels. These compounds target high medical needs and can be used to treat several ageing-related diseases resulting from insufficient local blood-circulation. The company was founded in 2015 by Reto Naef, who has been the CEO since then. | 5 years |
Alois C. Hopf | M | - |
Bottneuro AG
![]() Bottneuro AG Information Technology ServicesTechnology Services Bottneuro AG develops digital therapies for Alzheimer's disease by using electrical stimulation of glia cells in the brain. The company is based in Basel, Switzerland. The Swiss company was founded by Bekim Osmani, Alois C. Hopf, and Bekim Osmani has been the CEO since incorporation. | - |
Daniel Vasella | M | 70 |
TOPADUR Pharma AG
![]() TOPADUR Pharma AG Pharmaceuticals: MajorHealth Technology TOPADUR Pharma AG is a Swiss-based biotech company located in Schlieren. TOPADUR is a patient-oriented biotech company that aims to enhance the quality of life through cutting-edge research. The private company is developing a new class of compounds based on their innovative cgmp-enzyme regulation system, which corrects locally cgmp levels. These compounds target high medical needs and can be used to treat several ageing-related diseases resulting from insufficient local blood-circulation. The company was founded in 2015 by Reto Naef, who has been the CEO since then. | 4 years |
Darren Kerr | M | - |
Stratpharma AG
![]() Stratpharma AG Pharmaceuticals: MajorHealth Technology Stratpharma AG specializes in the development and licensing of novel medical devices and pharmaceutical products. Its products are used for scar management, abnormal scar prevention and invasive therapies. The company was founded in 2005 and is headquartered in Basel, Switzerland.^ | 19 years |
Dominik Escher | M | - |
TOPADUR Pharma AG
![]() TOPADUR Pharma AG Pharmaceuticals: MajorHealth Technology TOPADUR Pharma AG is a Swiss-based biotech company located in Schlieren. TOPADUR is a patient-oriented biotech company that aims to enhance the quality of life through cutting-edge research. The private company is developing a new class of compounds based on their innovative cgmp-enzyme regulation system, which corrects locally cgmp levels. These compounds target high medical needs and can be used to treat several ageing-related diseases resulting from insufficient local blood-circulation. The company was founded in 2015 by Reto Naef, who has been the CEO since then. | 6 years |
Günther Wess | M | - |
TOPADUR Pharma AG
![]() TOPADUR Pharma AG Pharmaceuticals: MajorHealth Technology TOPADUR Pharma AG is a Swiss-based biotech company located in Schlieren. TOPADUR is a patient-oriented biotech company that aims to enhance the quality of life through cutting-edge research. The private company is developing a new class of compounds based on their innovative cgmp-enzyme regulation system, which corrects locally cgmp levels. These compounds target high medical needs and can be used to treat several ageing-related diseases resulting from insufficient local blood-circulation. The company was founded in 2015 by Reto Naef, who has been the CEO since then. | 9 years |
Torleif Roykenes | M | - |
Stratpharma AG
![]() Stratpharma AG Pharmaceuticals: MajorHealth Technology Stratpharma AG specializes in the development and licensing of novel medical devices and pharmaceutical products. Its products are used for scar management, abnormal scar prevention and invasive therapies. The company was founded in 2005 and is headquartered in Basel, Switzerland.^ | - |
Silvia Scherer | F | - |
TOPADUR Pharma AG
![]() TOPADUR Pharma AG Pharmaceuticals: MajorHealth Technology TOPADUR Pharma AG is a Swiss-based biotech company located in Schlieren. TOPADUR is a patient-oriented biotech company that aims to enhance the quality of life through cutting-edge research. The private company is developing a new class of compounds based on their innovative cgmp-enzyme regulation system, which corrects locally cgmp levels. These compounds target high medical needs and can be used to treat several ageing-related diseases resulting from insufficient local blood-circulation. The company was founded in 2015 by Reto Naef, who has been the CEO since then. | 4 years |
Tino Töpper | M | - |
Bottneuro AG
![]() Bottneuro AG Information Technology ServicesTechnology Services Bottneuro AG develops digital therapies for Alzheimer's disease by using electrical stimulation of glia cells in the brain. The company is based in Basel, Switzerland. The Swiss company was founded by Bekim Osmani, Alois C. Hopf, and Bekim Osmani has been the CEO since incorporation. | - |
Rolf Wildermuth | M | - |
Bottneuro AG
![]() Bottneuro AG Information Technology ServicesTechnology Services Bottneuro AG develops digital therapies for Alzheimer's disease by using electrical stimulation of glia cells in the brain. The company is based in Basel, Switzerland. The Swiss company was founded by Bekim Osmani, Alois C. Hopf, and Bekim Osmani has been the CEO since incorporation. | - |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
Switzerland | 15 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Pascal Brenneisen
- Personal Network